Inhaled Nitric Oxide (iNO) Treatment of Early Pulmonary Hypertension to Reduce the Risk of Death or Bronchopulmonary Dysplasia in Extremely Preterm Infants: A Masked Randomized Controlled Trial
Saturday, April 26, 2025
7:45am – 8:00am HST
Location: Convention Center: Kalākaua Ballroom A (Level 4)
Publication Number: 2100.4
Hussnain Mirza, Advent Health for Children/ UCF College of Medicine, Orlando, FL, United States; Jorge A. Garcia, AdventHealth for Children, Orlando, FL, United States; Matthew Zussman, AdventHealth for Children, Orlando, FL, United States; Rajan Wadhawan, AdventHealth, Winter Park, FL, United States; William NMN. Oh, Women and Infants' Hospital, Barrington, RI, United States
Presenting Author(s)
Hussnain S. Mirza, MD. MBA (he/him/his)
Associate Professor Pediatrics Advent Health for Children/ UCF College of Medicine Orlando, Florida, United States